$4.5 million behind new pill to tackle Australia’s number one killer
A new pill designed to reduce the devastating toll of heart disease and stroke around the world has received a $4.5 million boost, thanks to a joint venture between The George Institute and Bupa Australia & New Zealand. READ MORE
New Executive Director to lead The George Institute, China
World renowned clinician-scientist Professor Craig Anderson is the new Executive Director of The George Institute, China, taking over from Professor Zhi-Jie Zheng. READ MORE
Climate change may be causing chronic kidney disease
Climate change may be accelerating rates of chronic kidney disease caused by dehydration and heat stress, according to a paper in the prestigious Clinical Journal of the American Society of Nephrology. READ MORE
Watch
SmartGenRx is a new venture between The George Institute and Bupa Australia & New Zealand to develop innovative pharmaceutical products for critical health problems.
High blood pressure linked to vascular dementia
High blood pressure could significantly raise the risk of developing the second most common form of dementia, according to a new study. READ MORE
Research finds opioids are pain in the back
New research has found that opioid painkillers, a common treatment for low back pain, provide minimal benefit. READ MORE
Major global study identifies a safer treatment of acute stroke
A modified dosage of a controversial clot busting drug has been shown to reduce serious bleeding in the brain and improve survival rates of stroke patients. READ MORE
The George Institute has won the “Excellence in Research and Development between Australia and India” award from the Australia India Business Council. READ MORE
"Because her wellbeing matters too..."
Executive Director of The George Institute, India, Professor Vivekanand Jha writes about gender equality in India. READ MORE
Study into blood pressure lowering named one of BMJ’s best of 2015
A study into the benefits of changing blood pressure lowering guidelines was shortlisted for UK Research Paper of the Year by the prestigious British Medical Journal. READ MORE
Roundtable: Better knowledge of pre-packaged food will help NCD management
The George Institute, China, has hosted a roundtable on Pre-packaged Food and Non-Communicable Diseases Prevention and Control, attended by researchers and members of government. READ MORE
George Clinical continues to expand its business development activities throughout the USA. This growth provides further evidence of the global trend towards conducting impactful clinical trials in the Asia-Pacific and engaging scientific leadership to manage them. READ MORE
Major global salt study going strong
Researchers in the five-year Salt Substitute and Stroke Study have met in Fengcheng of Liaoning province, a remote study site of the trial in northeastern China for their annual meeting. READ MORE
Medical Research Future Fund key to delivering a healthier Australia
The Medical Research Future Fund is an opportunity to catapult transformative change across the health system for the benefit of all Australians. READ MORE
Supporting Prevention 1st and greater investment in prevention
The George Institute commends the formation of the Prevention 1st Alliance; and echoes the call to Party Leaders to put preventative health policy first and act against the crisis of chronic disease affecting more than 1 in 2 Australians. READ MORE
Publications in 2016
229
to date, up from 132 in April
The mission of The George Institute for Global Health is to improve the health of millions of people worldwide.